Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Anti-Cancer Drugs|August 13, 2021
Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate dataAngela Dalia Ricci, Alessandro Rizzo, Veronica Mollica, et al.Frontiers in Molecular Biosciences|December 19, 2022
The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.Journal of Personalized Medicine|August 26, 2022
Molecular Profile and Prognostic Value of BAP1 Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database AnalysisAlessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, et al.Expert Opinion on Investigational Drugs|June 25, 2021
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?Alessandro Rizzo, Vincenzo Dadduzio, Angela Dalia Ricci, et al.Expert Opinion on Investigational Drugs|November 22, 2021
Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospectsAlessandro Rizzo, Angela Dalia Ricci, Laura Lanotte, et al.Cancers|April 30, 2021
Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?Angela Dalia Ricci, Alessandro Rizzo, Fabiola Lorena Rojas Llimpe, et al.Clinical & Experimental Metastasis|December 16, 2024
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysisAlessandro Rizzo, Fernando Sabino Marques Monteiro, Veronica Mollica, et al.European Urology Focus|March 14, 2021
Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical TrialsAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.Pathology, Research and Practice|April 15, 2021
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trialsAlessandro Rizzo, Veronica Mollica, Matteo Rosellini, et al.Expert Review of Molecular Diagnostics|May 6, 2026
Liquid biopsy for biliary tract cancer: available evidence and future research directionsEnes Erul, Angela Dalia Ricci, Mario Della Mura, et al.Pageof 9